These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 10669114)
1. Eicosanoid release in the endotoxin-primed isolated perfused rat lung and its pharmacological modification. Amann R; Schuligoi R; Peskar BA Inflamm Res; 1999 Dec; 48(12):632-6. PubMed ID: 10669114 [TBL] [Abstract][Full Text] [Related]
2. Effects of COX-1 and COX-2 inhibitors on eicosanoid biosynthesis and the release of substance P from the guinea-pig isolated perfused lung. Amann R; Schuligoi R; Peskar BA Inflamm Res; 2001 Jan; 50(1):50-3. PubMed ID: 11235022 [TBL] [Abstract][Full Text] [Related]
3. Effects of the cyclooxygenase-2 inhibitor NS-398 on thromboxane and leukotriene synthesis in rat peritoneal cells. Schuligoi R; Amann R; Prenn C; Peskar BA Inflamm Res; 1998 May; 47(5):227-30. PubMed ID: 9657255 [TBL] [Abstract][Full Text] [Related]
4. FMLP causes eicosanoid-dependent vasoconstriction and edema in lungs from endotoxin-primed rats. Voelkel NF; Czartolomna J; Simpson J; Murphy RC Am Rev Respir Dis; 1992 Mar; 145(3):701-11. PubMed ID: 1546853 [TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin. Uhlig S; Nüsing R; von Bethmann A; Featherstone RL; Klein T; Brasch F; Müller KM; Ullrich V; Wendel A Mol Med; 1996 May; 2(3):373-83. PubMed ID: 8784790 [TBL] [Abstract][Full Text] [Related]
6. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide. Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505 [TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of cyclooxygenase-2 by NS-398 in endotoxin shock rats in vivo. Futaki N; Takahashi S; Kitagawa T; Yamakawa Y; Tanaka M; Higuchi S Inflamm Res; 1997 Dec; 46(12):496-502. PubMed ID: 9459080 [TBL] [Abstract][Full Text] [Related]
8. Effects of inhibitors of the activity of cyclo-oxygenase-2 on the hypotension and multiple organ dysfunction caused by endotoxin: a comparison with dexamethasone. Leach M; Hamilton LC; Olbrich A; Wray GM; Thiemermann C Br J Pharmacol; 1998 Jun; 124(3):586-92. PubMed ID: 9647485 [TBL] [Abstract][Full Text] [Related]
9. [Leukocyte-mediated production of eicosanoids in rat lungs: modulation by a calcium antagonist]. Chida M; Voelkel NF; Ono S; Tanita T; Fujimura S Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1198-203. PubMed ID: 8583710 [TBL] [Abstract][Full Text] [Related]
10. Disturbance of peristalsis in the guinea-pig isolated small intestine by indomethacin, but not cyclo-oxygenase isoform-selective inhibitors. Shahbazian A; Schuligoi R; Heinemann A; Peskar BA; Holzer P Br J Pharmacol; 2001 Mar; 132(6):1299-309. PubMed ID: 11250881 [TBL] [Abstract][Full Text] [Related]
11. Suppressive effect of selective cyclooxygenase-2 inhibitor on cytokine release in human neutrophils. Kimura T; Iwase M; Kondo G; Watanabe H; Ohashi M; Ito D; Nagumo M Int Immunopharmacol; 2003 Oct; 3(10-11):1519-28. PubMed ID: 12946449 [TBL] [Abstract][Full Text] [Related]
12. Endotoxin priming of the cyclooxygenase-2-thromboxane axis in isolated rat lungs. Ermert M; Merkle M; Mootz R; Grimminger F; Seeger W; Ermert L Am J Physiol Lung Cell Mol Physiol; 2000 Jun; 278(6):L1195-203. PubMed ID: 10835325 [TBL] [Abstract][Full Text] [Related]
13. Modulation of pulmonary leukotriene formation and perfusion pressure by bestatin, an inhibitor of leukotriene A4 hydrolase. Muskardin DT; Voelkel NF; Fitzpatrick FA Biochem Pharmacol; 1994 Jul; 48(1):131-7. PubMed ID: 8043014 [TBL] [Abstract][Full Text] [Related]
15. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity. Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736 [TBL] [Abstract][Full Text] [Related]
16. Involvement of cyclooxygenase-2 in rat models of conjunctivitis. Oka T; Shearer T; Azuma M Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364 [TBL] [Abstract][Full Text] [Related]
17. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach. Gretzer B; Ehrlich K; Maricic N; Lambrecht N; Respondek M; Peskar BM Br J Pharmacol; 1998 Mar; 123(5):927-35. PubMed ID: 9535022 [TBL] [Abstract][Full Text] [Related]
18. Effects of selective and unselective cyclooxygenase inhibitors on prostanoid release from various rat organs. Tegeder I; Neupert W; Gühring H; Geisslinger G J Pharmacol Exp Ther; 2000 Mar; 292(3):1161-8. PubMed ID: 10688636 [TBL] [Abstract][Full Text] [Related]
19. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model. Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321 [TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]